It has been suggested that despite the differences in tumour biology the overexpression of YB-1 in nasopharyngeal cancer may also have clinicopathological significance as a predictive biomarker in HNSCC patients (Tay et al, 2009). Here, YBX1 is linked to head and neck squamous cell carcinoma.